BMEA
Biomea Fusion, Inc. · Healthcare
A2A Pharmaceuticals, Inc. sold $846K of Biomea Fusion, Inc.
10% owner
Sold$846,000
$33.84Price
25,000Shares
−1%Stake
What BMEA did after the filing
- The stock from Wed, May 17 open, $32.76
- −33.0%
- S&P 500, same days
- +7.9%
Measured over 30 trading days, to the Jun 30 close.
Traded Fri, May 12. Filed Wed, May 17, 3:13 AM ET, before the open. Returns use the May 17 open and the Jun 30 close. Not investment advice.